Lei, Wenjing
Liu, Zhuoliang
Su, Zhiyuan
Meng, Panpan
Zhou, Chun
Chen, Xiaomei
Hu, Zheng
Xiao, An
Zhou, Miaomiao
Huang, Liping
Zhang, Yiyue
Qin, Xianhui
Wang, Junping
Zhu, Fengxin
Nie, Jing
Funding for this research was provided by:
Nature and Science Foundation of China (81900609, 82170700, 81730019)
National Key R&D program of China (2020YFC2005001)
Nature and Science Foundation of Guangdong province (2019B1515120075)
Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110102004)
Article History
Received: 5 June 2023
Accepted: 17 July 2023
First Online: 27 July 2023
Declarations
:
: CSPPT was approved by the Ethics Committee of the Institute of Biomedicine, Anhui Medical University, Hefei, China (Federal Wide Assurance Number: FWA00001263). All participants gave written informed consent prior to data collection. hUCB samples were collected from the Nanfang Hospital, Guangzhou, Guangdong, China. Informed consent was obtained from donors, and the study was approved by the Nanfang Hospital's Ethics Committee and Research Ethics Advisory Committee (NFEC-2021-261). All procedures performed on the mice were approved by the Southern Medical University and following the Animal Experiments Ethics Committee. All work involving zebrafish was reviewed by the Animal Ethics Committee or the Animal Research Advisory Committee of South China University of Technology.
: Not applicable.
: The authors declare that they have no competing interests.